James Barder - Futura Medical CEO Director
| FUM Stock | 32.95 0.22 0.66% |
CEO
James Barder is CEO Director of Futura Medical
| Age | 65 |
| Address | Surrey Technology Centre, Guildford, United Kingdom, GU2 7YG |
| Phone | 44 14 8368 5670 |
| Web | https://www.futuramedical.com |
Futura Medical Management Efficiency
The company has return on total asset (ROA) of (0.2659) % which means that it has lost $0.2659 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4743) %, meaning that it generated substantial loss on money invested by shareholders. Futura Medical's management efficiency ratios could be used to measure how well Futura Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Futura Medical's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to 1.21, whereas Total Current Assets are forecasted to decline to about 5.2 M.Similar Executives
| Found 9 records | CEO Age | ||
| Jozsef Molnar | MOL Hungarian Oil | 68 | |
| Kyehyun Kyung | Samsung Electronics Co | 61 | |
| Jae Chang | Hyundai Motor | 60 | |
| Koji Sato | Toyota Motor Corp | 55 | |
| Akio Toyoda | Toyota Motor Corp | 68 | |
| Gill Pratt | Toyota Motor Corp | N/A | |
| Rene Haas | SoftBank Group Corp | 62 | |
| Kyehyun Kyung | Samsung Electronics Co | 61 | |
| DongSeock Lee | Hyundai Motor | 60 | |
Management Performance
| Return On Equity | -0.47 | ||||
| Return On Asset | -0.27 |
Futura Medical Leadership Team
Elected by the shareholders, the Futura Medical's board of directors comprises two types of representatives: Futura Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Futura. The board's role is to monitor Futura Medical's management team and ensure that shareholders' interests are well served. Futura Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Futura Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Angela Hildreth, Finance COO | ||
| Kevin Langridge, Head Quality | ||
| Graham Smith, Head Supply | ||
| James Barder, CEO Director | ||
| Kenneth James, Head Director | ||
| William Potter, Chief Board |
Futura Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Futura Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.47 | ||||
| Return On Asset | -0.27 | ||||
| Profit Margin | (0.45) % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 97.14 M | ||||
| Shares Outstanding | 303.7 M | ||||
| Shares Owned By Insiders | 32.01 % | ||||
| Shares Owned By Institutions | 35.18 % | ||||
| Price To Book | 12.94 X | ||||
| Price To Sales | 12.31 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Futura Stock
Futura Medical financial ratios help investors to determine whether Futura Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Futura with respect to the benefits of owning Futura Medical security.